Global prevalence of POAG

Slides:



Advertisements
Similar presentations
Cannabis e glaucoma Dott.ssa Anna Porcella Istituto di Neurogenetica e Neurofarmacologia Consiglio Nazionale delle Ricerche, Cagliari Roma 6 ottobre 2001.
Advertisements

Paras Guide to Glaucoma
Glaucoma Clinical Update Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012.
© INTERNATIONAL GLAUCOMA ASSOCIATION (274681) 2009 The International GLAUCOMA Association Subhash Suthar D Pharm Development Manager.
Global Burden of Disease, Injuries and Risk Factors Study Preliminary Result Estimates- Janet L. Leasher, OD, MPH, FAAO On behalf of the GBD Vision.
By Dr Obinna Awiaka O.D,MNOA President & CEO Eyemasters Ltd Occupational Vision Specialists.
Bitten by Ophthalmology Professor Helen Danesh-Meyer University of Auckland.
Glaucoma Glaucoma describes a number of ocular conditions characterized by: Raised intraocular pressure (IOP). Optic nerve head damage. Corresponding loss.
Glaucoma Region XI “The Hot Splinters”. Definition A group of diseases caused by damage to the optic nerve that can gradually eliminate all sight A group.
The Canadian Association of Optometrists
Clinical Rounds Taylor Strange, D.O. University of Louisville School of Medicine Department of Ophthalmology and Visual Sciences Friday, June 6th 2014.
Barrow, Brantley, Fredde, Gillispie
The healthy eye • Light rays enter the eye
Glaucoma Group of diseases characterized by increased intraocular pressure resulting in damage to the optic nerve and retinal nerve fibers.
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Will my Glaucoma patient lose vision ?
Adult Medical-Surgical Nursing Neurology Module: Glaucoma.
January is Glaucoma Awareness Month The information and recommendations appearing on these pages are informational only and is not intended to be a basis.
Visual Impairment. Factors Affecting Visual Function and Their Treatment Visual Acuity - ability to see "detail" –Measured using testing distance/letter.
How Do I Know My Glaucoma Treatment is Working? Dr Catherine Green Head: Glaucoma Unit RVEEH.
Introduction  Selective Laser Trabeculoplasty (SLT) uses a Q-Switched frequency- doubled (532 nm), low energy Nd:YAG laser, which targets melanocytes.
Dr. Abdullah Al-Amri Ophthalmology Consultant
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
Blindness or low vision effects more than 3 million Americans 40 years and older, and this number is projected to reach 5.5 million by In addition.
Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.
Chronic Visual Loss. CHRONIC VISUAL LOSS 1. Measure intraocular pressure with a tonometer 2. Evaluate the nerve head 3. Evaluate the clarity of the lens.
Volk Optical SLT Lens Distributor Product Presentation December, 2009.
Glaucoma.
PRIMARY OPEN ANGLE GLAUCOMA PROF.DR.ÖZCAN OCAKOĞLU.
Glaucoma Madhav Vempali Vempali Medical Ltd. Glaucoma The healthy eye Light rays enter the eye through the cornea, pupil and lens. These light rays are.
The Royal Victorian Eye and Ear Hospital 24-hour eye pressure and glaucoma Dr Simon Skalicky FRANZCO, MPhil, MMed (Ophthal Sci), MBBS (Hons 1) Visiting.
Perfusion Chamber with Porous Membrane for Cellular-Level Glaucoma Research Joey Labuz Holly Liske Laura Piechura Kellen Sheedy Donna Peters, PhD Department.
Glaucoma Lily T. Im, MD. What is glaucoma?   Glaucoma is a group of diseases that damage the eye’s optic nerve and can result in vision loss and blindness.
A Deeper Look at Sight Threatening Conditions: Glaucoma, Macular Degeneration, and Diabetic Retinopathy Ashley S. Reddell, OD, FCOVD HOACLS 2015.
(Relates to Chapter 22, “Nursing Management: Visual and Auditory Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier.
Understanding Glauco ma. Femi Babalola Rachel eye center Garki, Abuja.
Glaucoma “ The Sneak Thief of Sight." Julie DeMore Professor Don Williams NS215G.
Cardiovascular Risk: A global perspective
Sensory.
Blood Reflux In Schlemm’s Canal Of Normal Cataract Patients: Simple Way To Identify The Trabecular Meshwork With Healthy Collector Channel Masahiro Maeda1,
iStent with phacoemulsification, n=50
“Your Amazing Research Topic”
Secondary Glaucoma Dated :
PROTECTING CELLS IN THE EYE AT RISK OF DAMGE FROM GLAUCOMA
Glaucoma.
Characteristics of Primary Angle-Closure Glaucoma Patients with Normal Intraocular Pressure at the First Visit Won Hyuk Oh1, Bum Gi Kim1, Joo Hwa Lee2.
INTRODUCTION TO GLAUCOMA
VISUAL ALTERATION GLAUCOMA.
Review of Glaucoma Suspect
Early Intraocular Pressure Rise After Phacoemulsification In Non-Glaucomatous And Eyes With Primary Open-Angle Glaucoma Milos Todorovic 1, Suncica Sreckovic.
Efficacy and safety of Ripasudil in patients with glaucoma insufficiently controlled under multiple medical therapies ● Yoshikuni Arakaki MD, Michiko Yonahara.
SECONDARY GLAUCOMAS Dr. Shinisha Paul.
B. Kozomara, E. Potkonjak, R. Lazic, N. Gabric
Pathogenesis of Glaucoma Translaminar-pressure difference
Blood Reflux In Schlemm’s Canal Of Normal Cataract Patients: Simple Way To Identify The Trabecular Meshwork With Healthy Collector Channel Masahiro Maeda1,
EVIDENCE LEVEL III CONFIRMATORY
Effect of Selective Laser Trabeculoplasty on
INTRODUCTION TO GLAUCOMA
IOP = intraocular pressure; SD = standard deviation.
Glaucoma Clinical features and management
David B Henson Medical School University of Manchester
Glaucoma.
© Coherent market Insights. All Rights Reserved Glaucoma Therapeutics Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018–2026.
Winthrop University Hospital
Glaucoma Progression.
Functional Tests in Glaucoma Marc Sarossy
Glaucoma Introduction DR ANUPAMA .B.
Kristina E. Fittipaldi, BA
Presentation transcript:

Global prevalence of POAG From systematic reviews of published population based studies Global prevalence (2013): 3.05% of the 40-80 year population has POAG Highest : Africa with 4.2% Estimated number globally(2013) : 44 million Highest : Asia with 23.5 % ( mostly related to the largest population) Tham et al. Ophthalmology 2014;121:2081-209

Tham et al. Ophthalmology 2014;121:2081-209

Risk factors Older age Male gender Urban residence African ancestry Most glaucoma is undetected ( 40- 90%, depending on the region) Tham et al. Ophthalmology 2014;121:2081-209

Pathophysiology of Primary open angle glaucoma (POAG) Primary open angle glaucoma is considered to be a chronic, progressive optic neuropathy characterised by typical optic nerve head and nerve fibre layer changes. Progressive ganglion cell loss and visual field changes are characteristic of the disease. Damage to the optic nerve is most commonly intraocular pressure dependent. Elevated IOP occurs secondary to changes in the trabecular meshwork

Components of the trabecular meshwork (TM ) TM beams Endothelial Cells lining TM Juxtracanalicular space Extracellular matrix Glycosaminonglaycans (GAG) Originally thought to fill all the empty spaces – now thought to only coat them

TM and IOP fluctuations Changes in the structure

TM and IOP fluctuations Low IOP High IOP Collapse of TM Widening of Schlemn’s canal Expansion of TM Collapse of Schlemn’s canal

In POAG Different theories Changes seen in the Trabecular meshwork are consistent

Tabecular meshwork beams

Trabecular meshwork

Increased resistance to outflow Increased IOP

Low IOP High IOP Schelmn’s canal Schelmn’s canal Trabecular meshwork Trabecular meshwork

Low IOP High IOP Schelmn’s canal Schelmn’s canal Trabecular meshwork Trabecular meshwork Collapse of Schlemn’s canal with Persistently high IOP

Changes in POAG TM beams : Thicken Cells lining TM : get lost – fusion of beams ? Also increase buildup of GAG Plaque deposition Juxtacanalicular space extracellular matrix Glycosaminonglaycans (GAG) Originally thought to fill all the empty spaces – now thought to only coat them Collapse of Schlem’s canal with repeated high IOP